Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)

Iraq Balks at Joining OPEC Cuts
27:48 - Oil investors are playing it safe as OPEC tries to finalize its deal to limit output. More talks are planned this week but there are new doubts about the plan. Bloomberg's Ben Sharples reports on "Bloomberg Markets." (Source: Bloomberg)
  • The Effect of the Human Body on Trading
  • BBHO Tops Rinehart's Bid for Kidman Cattle Empire
  • Malaysia's Budget Targets Loyal Voters